Now See this:

THE ROCKEFELLER PLAYBOOK: OPERATION LOCKSTEP 1St PHASE

Common cold/flu. Mild symptoms at most.

Media endorsement of mass paranoia and fear.

Flawed testing system utilised. which picks up any genetic material in the body and triggers a positive result.

Inflation of Covid case numbers through the changing of death certificates, double counting, classifying all deaths including other diseases and natural causes as Covid19.

Lockdown will condition people to life under Draconian Laws, prevent protests and identify public resistance.

2nd PHASE

The 1st Phase will lead to compromised and frail immune systems through lack of food, social distancing, wearing of masks, lack of sunlight and healthy bacteria.

Exposure to 5G radiation will further attack the immune system. Thus when people re-merge into society, more people will fall ill. This will be blamed on Covid19.

This will all occur before the vaccination is ready to justify it.

A longer and more potent lockdown will follow until everyone takes the vaccine.

3rd Phase

If a majority of people resist the vaccine, a weaponised SARS/HIV/MERS virus will be released.

A lot of people will die from this.

It will be the survival of the fittest.

It will also be the ultimate push for everyone to be vaccinated in order to return to normality.

Those who have taken the vaccine will be at war with those who have not. It will be anarchy from all sides.

System and Method for Testing for COVID-19 Patent 2016

Rechter muisklik om US2020279585 (A1) - System and Method for Testing for favoriet te maken COVID-19

Uitvinder(s): ROTHSCHILD RICHARD A [GB] +

Aanvrager(s): ROTHSCHILD RICHARD A [GB] +

G06K9/00; G11B27/031; G11B27/10;

internationaal: G16H40/63; H04N5/76; H04N9/82

G06K9/00892 (US); G11B27/031 (US);

Classificatie:

G11B27/10 (US); G11B27/102 (US);

G16H40/63 (EP, US); G16H40/67 (EP);

• cooperative. G16H50/20 (Ep). H04N5/76 (Ep US).

H04N9/8205 (EP, US); G06K2009/00939

(US)

Aanvraagnummer: US202016876114 20200517 Global Dossier US202016876114 20200517 ; US201916704844 20191205 ; Prioriteitsnummer(s): US201916273141 20190211 ; US201715495485 20170424; US201615293211 20161013 ; US201562240783P 20151013

Samenvatting van US2020279585 (A1)

Vertaal deze tekst Tooltip

A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted wirelessly to a smartphone. To ensure that the data is accurate, an accelerometer within the smartphone is used to measure movement of the smartphone and/or the user. Once accurate data is acquired, it is uploaded to the cloud (or host), where the data is used (alone or together with other vital signs) to determine whether the user is suffering from (or likely to suffer from) a viral infection, such as COVID-19. Depending on the specific requirements, the data, changes thereto, and/or the determination can be used to alert medical staff and take corresponding actions.

• Sitemap

• Accessibility

• Legal notice

• Terms of use

Last updated: 22.06.2016 Worldwide Databank 6.3.5.00.1; 93p